Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe save search
AgriFORCE Growing Systems Announces Binding LOI to Acquire a Leading European Agriculture/Horticulture and AgTech Consulting Firm, with Global Operations and 2020 Annual Revenues of US$26 million and EBITDA of US$3 million (IFRS Based)
Published: 2021-10-27 (Crawled : 13:00) - globenewswire.com
AGRI | $0.163 8.59% 7.91% 4.8M
|
|
| O: 0.0%
H: 231.02%
C: 46.76%
europe growing
Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture
Published: 2023-06-26 (Crawled : 12:00) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -50.0%
H: 200.0%
C: 100.0%
Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -50.0%
H: 150.0%
C: 125.0%
approval canada
Curis Reports Updated Data in Two Abstracts for CA-4948 Accepted for Presentation at the European Hematology Association 2021 Virtual Congress
Published: 2021-05-12 (Crawled : 15:15) - prnewswire.com
CRIS | $14.59 -4.14% -4.32% 10K
|
Health Technology
|
| O: -1.73%
H: 80.12%
C: 68.43%
presentation europe ca-4948
Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa
Published: 2023-02-14 (Crawled : 13:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -20.63%
H: 49.0%
C: 25.0%
td011 treatment trial therapeutics
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe
Published: 2023-06-12 (Crawled : 16:00) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -25.6%
H: 47.85%
C: 42.47%
InflaRx Announces Plans to Apply for Emergency Use Authorization from the US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients
Published: 2022-07-26 (Crawled : 12:20) - biospace.com/
IFRX | $1.36 7.94% 7.35% 140K
|
Health Technology
|
| O: 6.47%
H: 44.59%
C: 29.73%
covid-19 treatment fda authorization emergency use authorization
Autolus Therapeutics to Present New Data on AUTO1 in r/r Indolent B Cell Lymphomas at the European Hematology Association Virtual Congress
Published: 2021-05-12 (Crawled : 14:15) - globenewswire.com
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: -2.0%
H: 42.74%
C: 38.24%
europe t-cell
Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago
Published: 2022-09-22 (Crawled : 07:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -20.21%
H: 40.17%
C: 33.19%
trial approval therapeutics initiated
atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression
Published: 2023-01-06 (Crawled : 15:20) - biospace.com/
ATAI | $1.85 -3.14% -3.24% 940K
|
Manufacturing
|
| O: -42.97%
H: 33.33%
C: 21.33%
pcn-101 sciences life trial depression phase 2b
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
Published: 2023-02-28 (Crawled : 12:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -13.04%
H: 32.5%
C: 31.5%
day rare disease therapeutics
Venus Concept Announces CE Mark for Venus Versa Pro in Europe
Published: 2024-02-22 (Crawled : 12:30) - globenewswire.com
VERO | $0.85 1.19% 1.18% 15K
|
Health Technology
|
| O: 37.7%
H: 31.85%
C: 10.71%
europe pro
SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022
Published: 2022-10-06 (Crawled : 12:00) - biospace.com/
SOPH | $4.93 2.71% 2.64% 51K
|
|
| O: 1.52%
H: 31.16%
C: -1.12%
financial
RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. Extend Their Stay of Pending Litigation to Provide Additional Time for The Parties to Finalize Their Settlement
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -13.46%
H: 28.44%
C: 20.0%
therapeutics
ReneSola Power and Eiffel Investment Group Announce MOU for Joint Venture to Fund Solar Development in Europe
Published: 2021-01-05 (Crawled : 12:06) - prnewswire.com
SOL | News | $1.7 -2.3% 0.0% 340K
|
Electronic Technology
|
| O: -2.51%
H: 27.55%
C: 18.23%
solar europe
Europe Frontotemporal Dementia Market Research Report 2023: Growing Prevalence of Dementia & Increasing Number of Clinical Trials - Competition, Forecasts & Opportunities to 2028
Published: 2023-04-26 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.22%
H: 0.65%
C: -1.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: -2.04%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.66%
H: 0.18%
C: -0.9%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 1.23%
H: 27.27%
C: -15.76%
europe report dementia trials research growing market
Exscientia Highlights "The Future of AI-enabled Drug Discovery" at SLAS Europe
Published: 2023-05-22 (Crawled : 12:20) - biospace.com/
EXAI | $4.24 -2.75% -2.83% 370K
|
|
| O: 1.66%
H: 27.04%
C: 25.24%
europe drug
Trinity Biotech Announces Q3 2023 Financial Results & Business Update-Investor call to be held today at 8:30 am EST
Published: 2024-01-31 (Crawled : 21:00) - biospace.com/
TRIB | $1.81 -3.72% -3.87% 5.7K
|
Health Technology
|
| O: 15.22%
H: 25.72%
C: 17.74%
biotech business financial results today
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
Published: 2023-01-24 (Crawled : 16:00) - biospace.com/
NMRD | $0.0798 -28.78% 28K
|
Health Technology
|
| O: 9.09%
H: 25.0%
C: 7.46%
medical study
Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe
Published: 2023-06-16 (Crawled : 12:20) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K
|
Health Technology
|
| O: 1.75%
H: 24.74%
C: 5.5%
europe medical cardiovascular
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.